Valvular and Nonvalvular Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement

• Published in: JACC. Cardiovascular interventions Vol. 13; no. 18; pp. 2124 - 2133
• Main Authors: Okuno, Taishi, Hagemeyer, Daniel, Brugger, Nicolas, Ryffel, Christoph, Heg, Dik, Lanz, Jonas, Praz, Fabien, Stortecky, Stefan, Räber, Lorenz, Roten, Laurent, Reichlin, Tobias, Windecker, Stephan, Pilgrim, Thomas
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 28.09.2020
• Subjects: atrial fibrillation; mitral stenosis; nonvalvular atrial fibrillation; transcatheter aortic valve replacement; valvular atrial fibrillation; atrial fibrillation; CVE; valvular atrial fibrillation; AF; mitral stenosis; CI; transcatheter aortic valve replacement; HR; TAVR; nonvalvular atrial fibrillation
• ISSN: 1936-8798; 1876-7605; 1876-7605
• DOI: 10.1016/j.jcin.2020.05.049

The aim of this study was to investigate the impact of valvular and nonvalvular atrial fibrillation (AF) in patients undergoing transcatheter aortic valve replacement (TAVR). AF has been associated with adverse clinical outcomes after TAVR. However, the differential impact of valvular as opposed to nonvalvular AF has not been investigated. In a retrospective analysis of a prospective registry, valvular AF was defined as AF in the setting of concomitant mitral stenosis or the presence of a mitral valve prosthesis. The presence of mitral stenosis was determined by pre-procedural echocardiography. The primary endpoint was a composite of cardiovascular death or disabling stroke at 1 year after TAVR. Among 1,472 patients undergoing TAVR between August 2007 and June 2018, AF was recorded in 465 patients (31.6%) and categorized as nonvalvular in 376 (25.5%) and valvular in 89 (6.0%). AF scores including HAS-BLED, CHADS2, and CHA2DS2-VASc were comparable between patients with nonvalvular and valvular AF. The primary endpoint occurred in 9.3% of patients with no AF, in 14.5% of patients with nonvalvular AF (hazard ratio: 1.57; 95% confidence interval: 1.12 to 2.20; p = 0.009), and in 24.2% of patients with valvular AF (hazard ratio: 2.75; 95% confidence interval: 1.71 to 4.41; p < 0.001). Valvular AF conferred an increased risk for cardiovascular death or disabling stroke compared with nonvalvular AF (hazard ratio: 1.77; 95% confidence interval: 1.07 to 2.94; p = 0.027). The presence of valvular AF in patients undergoing TAVR increased the risk for cardiovascular death or disabling stroke compared with both no AF and nonvalvular AF. (SWISS TAVI Registry; NCT01368250) [Display omitted]